Quarterly guidance has enhanced confidence in UNH stock price forecast, with forward P/E ratios remaining attractive compared to peers in the healthcare insurance segment. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Beyond the guidance, a credible and aggressive turnaround plan fuels the market's renewed optimism. Management has clearly articulated a multi-pronged strategy to address the core issues that have pressured the company's performance and profitability. UNH stock price forecast for mid-2024 incorporates projected EPS growth of 11% year-over-year, bolstered by strategic acquisitions and cost management in healthcare administration.